Companies / Financials
C
Citigroup
Diversified Banks
Diversified BanksAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health71
Growth41
Profitability73
Cash generationn/a
Balance sheetn/a
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2025-09-30)9.3%Revenue growth (FY)5.6%Revenue CAGR (3y)4.2%Gross margin—Operating margin—Net margin16.8%Free cash flow margin-87.0%R&D / revenue—Stock comp / revenue—Net debt / operating cash flow—Current ratio—Diluted share count change-3.5%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $71.9B | $75.3B | $78.1B | $80.7B | $85.2B |
| Net income | $22.0B | $14.8B | $9.2B | $12.7B | $14.3B |
| Operating cash flow | $47.1B | $25.1B | -$73.4B | -$19.7B | -$67.6B |
| Capital expenditure | $4.1B | $5.6B | $6.6B | $6.5B | $6.5B |
| Free cash flow | $43.0B | $19.4B | -$80.0B | -$26.2B | -$74.2B |
| Buybacks | $7.6B | $3.2B | $2.0B | $2.5B | $13.2B |
| Dividends | $5.2B | $5.0B | $5.2B | $5.2B | $5.4B |
| Cash | $262.0B | $342.0B | $260.9B | $276.5B | $349.6B |
| Total debt | $282.3B | $318.7B | $324.1B | $335.8B | $367.7B |
| Equity | $202.0B | $201.2B | $205.5B | $208.6B | $212.3B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.